Quick Answer
NEOGENOMICS INC reported Net Income of -$108.03 million for fiscal year 2025.
NEOGENOMICS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$108.03M | -37.2% |
| 2024 | -$78.73M | +10.5% |
| 2023 | -$87.97M | +39.0% |
| 2022 | -$144.25M | -1628.2% |
| 2021 | -$8.35M | -300.1% |
| 2020 | $4.17M | -47.9% |
| 2019 | $8.01M | +203.3% |
| 2018 | $2.64M | +766.7% |
| 2017 | -$396.0K | +93.6% |
| 2016 | -$6.14M | -142.3% |
| 2015 | -$2.54M | -323.9% |
| 2014 | $1.13M | -44.3% |
| 2013 | $2.03M | +3027.7% |
| 2012 | $65.0K | +105.5% |
| 2011 | -$1.18M | +64.4% |
| 2010 | -$3.30M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$27.13M | -53.3% | +39.8% |
| June 30, 2025 | -$45.09M | -141.9% | -73.9% |
| March 31, 2025 | -$25.92M | +4.2% | -46.5% |
| September 30, 2024 | -$17.70M | +4.4% | +5.1% |
| June 30, 2024 | -$18.64M | +23.4% | +31.1% |
| March 31, 2024 | -$27.06M | +12.1% | -46.1% |
| September 30, 2023 | -$18.52M | +49.8% | +23.9% |
| June 30, 2023 | -$24.33M | +31.1% | +21.0% |
- NEOGENOMICS INC showed a decrease of -37.2% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, NEOGENOMICS INC’s net income has declined by 3170.5% (from -$3.30 million to -$108.03 million).
- The most recent figure is from NEOGENOMICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: